Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development.
Habib R, Roark RS, Li H, Connell AJ, Hogarty MP, Wagh K, Wang S, Marchitto L, Skelly AN, Carey JW, Sowers KJ, Ayyanathan K, Plante SJ, Bibollet-Ruche F, Park Y, Agostino CJ, Singh A, Martella CL, Lewis E, Rando JM, Chohan N, Lora J, Ding W, Campion MS, Zhao C, Liu W, Li Y, Li X, Liang B, Chowdhury RR, Amereh K, Itallie EV, Sheng Z, Ghosh AR, Bar KJ, Williams WB, Wiehe K, Saunders KO, Edwards RJ, Cain DW, Lewis M, Batista FD, Burton DR, Andrabi R, Kulp DW, Haynes BF, Korber B, Shapiro L, Kwong PD, Hahn BH, Shaw GM. Habib R, et al. Among authors: chowdhury rr. bioRxiv [Preprint]. 2025 May 29:2025.05.03.652068. doi: 10.1101/2025.05.03.652068. bioRxiv. 2025. PMID: 40502159 Free PMC article. Preprint.
Cohort profile: the BangladEsh Longitudinal Investigation of Emerging Vascular and nonvascular Events (BELIEVE) cohort study.
Chowdhury R, Khan N, Pennells L, Iurilli MLC, Uddin Miah MT, Monower MM, Rahman KMT, Samin S, Saqeeb KN, Tasmin I, Farrow E, Farrow S, Michielsen A, Perry C, Spackman S, van Coeverden C, Walker M, Ahmed T, Ajioka J, Awal KAA, Butterworth AS, Chatzidiakou E, Feldmann J, Fenner R, Flora MS, Haque T, Hawkes S, Islam SS, Islam S, Jones RL, Kaptoge S, Khan KH, King L, Luhar S, Malik A, Malik FT, Naved RT, Naheed A, Popoola O, Raqib R, Shirin T, Sutton S, van Daalen KR, Wood A, Griffin S, Mascie Taylor N, Khalequzzaman M, Khan MA, Choudhury SR, Di Angelantonio E, Danesh J; BELIEVE Study. Chowdhury R, et al. BMJ Open. 2025 Jan 22;15(1):e088338. doi: 10.1136/bmjopen-2024-088338. BMJ Open. 2025. PMID: 39843382 Free PMC article.
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, Hudson E, Panades M, Mathew T, Anand A, Persic M, Forrest J, Bhana R, Reed N, Drake A, Adusumalli M, Mukhopadhyay A, King M, Whitmarsh K, McGrane J, Colombo N, Mak C, Mandal R, Chowdhury RR, Alamilla-Garcia G, Chávez-Blanco A, Stobart H, Feeney A, Vaja S, Hacker AM, Hackshaw A, Ledermann JA; INTERLACE investigators. McCormack M, et al. Among authors: chowdhury rr. Lancet. 2024 Oct 19;404(10462):1525-1535. doi: 10.1016/S0140-6736(24)01438-7. Epub 2024 Oct 14. Lancet. 2024. PMID: 39419054 Free article. Clinical Trial.
53 results